Wholesalers Ask 2nd Circ. To Toss Shire Pay-For-Delay Win

Law360, New York (March 17, 2014, 3:13 PM EDT) -- Attorneys for drug wholesalers claiming Shire LLC smothered generic competition for attention-deficit-hyperactivity drug Adderall XR told a Second Circuit panel Monday that a district court wrongly concluded that Shire's alleged breaches of patent licensing agreements aren't actionable under federal antitrust law.

The wholesalers’ attorney Joseph Opper of Garwin Gerstein & Fisher LLP asked a three-judge panel in Manhattan to expand its legal precedent surrounding Section 2 of the Sherman Act to allow nonparties to a pay-for-delay deal between brand and generic drug manufacturers to obtain antitrust damages...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.